About

NovaMechanics is a leading research and innovation company specializing in Artificial Intelligence, Machine Learning, Chemoinformatics, Bioinformatics, and Data Analytics. With active participation in more than 40 EU and national R&D projects, we develop pioneering informatics solutions such as the Isalos Analytics Platform, Enalos Cloud, Asclepios Drug Discovery tools and Pharos Databases. Our mission is to accelerate digital transformation in science and industry through intelligent, data-driven technologies.

Solution & Product

NovaMechanics develops advanced digital solutions that apply Artificial Intelligence (AI), Machine Learning (ML), and Data Analytics to accelerate research and innovation. Our flagship products include the Isalos Analytics Platform, a no-code environment for predictive modeling and optimization; the Enalos Cloud Platform, offering integrated computational tools for chemistry, biology, and materials science; the Asclepios Drug Discovery tools, enabling AI/ ML-driven drug repurposing / discovery and safety assessment; and the Pharos Databases, providing curated scientific data for nanotechnology and life sciences. Together, these tools empower industries and researchers to make faster, smarter, and data-driven decisions.

Innovation & Scalability

NovaMechanics drives digital transformation through innovative AI- and data-driven technologies designed for scalability across sectors. Our platforms—Isalos Analytics and Enalos Cloud—offer a modular, cloud-based, and no-code environment that enables companies to integrate predictive analytics and optimization tools into their daily operations without the need for programming expertise. This approach reduces development costs, accelerates time-to-market, and enhances decision-making across industries such as pharma, materials, chemicals, and manufacturing. With a strong foundation of over 40 EU and national R&D projects, NovaMechanics continuously transforms cutting-edge research into market-ready digital solutions, ensuring sustainable business growth and global scalability.

Traction & achievements

NovaMechanics has established itself as a trusted technology partner in Europe’s research and innovation ecosystem. The company has successfully participated in over 40 EU and national R&D projects, collaborating with top academic institutions, research centers, and industry leaders. Our solutions—Isalos Analytics, Enalos Cloud, Asclepios Drug Discovery tools, and Pharos Databases—are already used by hundreds of researchers and industrial partners across Europe. NovaMechanics has been recognized for its excellence in AI, Machine Learning, and Data Analytics, coordinating large-scale initiatives such as NanoSolveIT and CompSafeNano, and contributing to the development of the next generation of digital science platforms that enable data-driven innovation and competitiveness.

Team & Why Us

NovaMechanics combines scientific excellence, technological innovation, and proven market experience to deliver end-to-end digital transformation solutions. Our unique strength lies in uniting deep expertise in AI, Machine Learning, Chemoinformatics, and Bioinformatics with a strong record of translating research into commercial success. We maintain strategic collaborations with leading universities, research centers, and industries across Europe, ensuring continuous innovation and knowledge exchange. Our proprietary cloud infrastructure and custom-built software platforms enable scalable, high-performance solutions tailored to diverse client needs. With a multidisciplinary team of >30 experts, including 17 PhD holders, and researchers recognized among the World’s Top 2% Scientists (Stanford University List), NovaMechanics delivers credible, impactful, and future-ready technologies that empower businesses and research organizations worldwide.

Funding Needs

NovaMechanics is a financially self-sustained company with established revenue streams. At this stage, we do not seek external investment. Our focus is on strategic reinvestment of cash flow to support continuous innovation, infrastructure expansion, and market growth. We remain open to discussing partnerships and collaborations that align with our strategic objectives and contribute to scaling our digital solutions globally.